Swiss Re and Roche Team Up in China

The idea is to provide insurance so patients can buy cancer drugs

Roche Holding has found a way to sell its cancer drugs to millions of Chinese who couldn’t otherwise afford them: First, sell them insurance. The world’s biggest maker of cancer medicines is collaborating with Swiss Re, the world’s second-largest reinsurer, to sell policies that are on track to bring in 10 million clients this year, says Harald Sprenger, Roche’s director of private insurance. They expect enrollment to jump 20 percent next year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.